Research progress for the clinical application of radionuclide labeling fibroblast activation protein inhibitor in the diagnosis and treatment of liver cancer

Journal Title: 中国临床医学(Chinese Journal of Clinical Medicine) - Year 2024, Vol 31, Issue 5

Abstract

Liver cancer has high morbidity and mortality worldwide. Traditional morphological imaging can offer crucial anatomical information for the diagnosis and treatment of liver cancer, and when combined with the functional data shown by PET imaging, the diagnostic accuracy of tumors can be further improved and assisted in treatment selection. Fibroblast activation protein (FAP), a signature protein of cancer-associated fibroblasts, is highly expressed in a variety of malignant tumors of epithelial origin and is an important target for tumor diagnosis and treatment. Compared with routinely applied 18F-fluorodeoxyglucose (FDG) PET imaging, FAP inhibitor (FAPI) PET imaging has the advantages of high image contrast and independence from blood glucose. In recent years, a variety of radiopharmaceuticals targeting FAP have been continuously expanded in the diagnosis, staging and targeted therapy of different liver cancer types, and the progress of their related applications is reviewed in this paper.

Authors and Affiliations

Yibo HE,Hongcheng SHI,

Keywords

Related Articles

Sex differences in the efficacy of first-line PD-1 blockade plus chemotherapy in patients with advanced lung adenocarcinoma

ObjectiveTo explore the impact of sex on the efficacy of first-line programmed death-1 (PD-1) blockade plus chemotherapy in patients with advanced lung adenocarcinoma and its potential biological mechanisms. MethodsThe c...

Clinical and translational mode of single-cell measurements: clinical artificial intelligent single-cell

With rapid development and maturity of single-cell measurements, single-cell biology and pathology has become an emerging discipline to understand the disease. However, it is important to address concerns raised by clini...

The relationship between dietary fiber intake and hypertension: an analysis based on the NHANES data from 2015—2016 in the United States

ObjectiveTo explore the relationship between dietary fiber intake and hypertension in different populations. MethodsDietary fiber intake was calculated using the data from 2015—2016 National Health and Nutrition Examinat...

Application effect of different incision surgeries combined with respiratory function exercise under the guidance of enhanced recovery after surgery concept in patients with lung cancer

ObjectiveTo explore the efficacy of different incision surgeries combined with respiratory function exercise under the guidance of enhanced recovery after surgery (ERAS) in lung cancer patients. MethodsFrom January 2020...

Clinical significance of Yes-associated protein 1 in esophageal squamous cell carcinoma

ObjectiveTo explore the expression and clinical significance of Yes-associated protein 1 (YAP1) in esophageal squamous cell carcinoma. MethodsImmunohistochemical method was used to detect YAP1 expression in 439 cases of...

Download PDF file
  • EP ID EP749360
  • DOI -
  • Views 22
  • Downloads 0

How To Cite

Yibo HE, Hongcheng SHI, (2024). Research progress for the clinical application of radionuclide labeling fibroblast activation protein inhibitor in the diagnosis and treatment of liver cancer. 中国临床医学(Chinese Journal of Clinical Medicine), 31(5), -. https://europub.co.uk/articles/-A-749360